#USA #New York #Levi & Korsinsky #Securities Class Action #Park Ha Biological

Important Update for Park Ha Biological Technology Investors

On September 9, 2026, Levi & Korsinsky, LLP, a renowned law firm specializing in securities litigation, issued a critical notice to investors involved in Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH). The firm informed investors about a pending securities class action that is set to address allegations surrounding the company's recent Initial Public Offering (IPO).

Background of the Allegations

The lawsuit contends that BYAH's IPO was structured in a way that limited public share availability to just 1,200,000 shares, representing less than 5% of the total company shares. This approach, as alleged in the lawsuit, created opportunities for price manipulation leading up to a disastrous collapse in share value. On July 8, 2025, the stock experienced a staggering decline of approximately 93%, resulting in a significant loss of market capitalization—over $1 billion—in a single trading session.

The lawsuit aims to hold the company accountable for the lack of transparency regarding the financial status of the firm and its share structure, which the plaintiffs argue led to misleading investor expectations. Joseph E. Levi, an attorney at Levi & Korsinsky, remarked, "Investors deserve transparency about material risks that could affect their investments". This sentiment echoes the core of the lawsuit, which seeks to uncover the truth behind the false narratives circulated during the promotional phase.

Key Deadlines and Legal Process

According to court documents, the deadline for investors to apply for lead plaintiff designation is September 28, 2026. The lead plaintiff, once appointed, will represent all class members in the litigation. Investors who purchased BYAH securities between December 27, 2024, and July 8, 2025, and suffered financial losses are encouraged to assess their eligibility for involvement in the lawsuit.

Specific Allegations

The lawsuit outlines several key points regarding the alleged misleading nature of BYAH's IPO:
1. Inadequate Public Float: The low percentage of shares available for public trading created a precarious situation, offering the potential for manipulated price surges.
2. Promotional Campaign Effects: The price of BYAH shares skyrocketed from $4.00 to an artificial high of $41.49 within just one trading day, before crashing back to substantial losses.
3. Failure to Address Market Manipulation: The management's lack of timely responses to rumors and promotional claims contributed to a detachment of the stock price from the underlying business operations, including a purportedly non-existent partnership with a major global cosmetics company.

What Investors Should Do

Investors affected by the collapse of BYAH shares are advised to gather necessary documentation, such as brokerage records detailing purchase dates and quantities of shares acquired, to facilitate their potential participation in the class action. Levi & Korsinsky offers a free initial evaluation to those who contact them. The law firm operates on a contingency fee basis, so there are no upfront costs for investors seeking to register their claims.

Conclusion

The developments surrounding BYAH and the forthcoming securities class action represent a significant opportunity for affected investors to seek restitution for their losses. As the deadline approaches, it is crucial to stay informed and take necessary action to assert one's rights in this ongoing legal process. Investors are encouraged to reach out to Levi & Korsinsky for guidance and support as this case unfolds.